Metformin therapy improves the menstrual pattern with minimal endocrine and metabolic effects in women with polycystic ovary syndrome
- 1 April 1998
- journal article
- research article
- Published by Elsevier BV in Fertility and Sterility
- Vol. 69 (4), 691-696
- https://doi.org/10.1016/s0015-0282(98)00011-9
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Decreases in Ovarian Cytochrome P450c17α Activity and Serum Free Testosterone after Reduction of Insulin Secretion in Polycystic Ovary SyndromeThe New England Journal of Medicine, 1996
- Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancyMetabolism, 1994
- Cardiovascular Disease Risks, Insulin Resistance, and Androgen ExcessSeminars in Reproductive Medicine, 1994
- Molecular Mechanisms of Insulin Resistance in the Polycystic Ovary SyndromeSeminars in Reproductive Medicine, 1994
- Management of non-insulin-dependent diabetes mellitusThe Lancet, 1994
- Clinical implications of hyperinsulinaemia in womenClinical Endocrinology, 1993
- Endometrial carcinoma; ovarian dysfunction — a risk factor in young womenEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 1991
- EFFECT OF INSULIN-LIKE GROWTH FACTOR-TYPE I (IGF-I) AND INSULIN ON THE SECRETION OF SEX HORMONE BINDING GLOBULIN AND IGF-I BINDING PROTEIN (IBP-I) BY HUMAN HEPATOMA CELLSJournal of Endocrinology, 1990
- Profound Peripheral Insulin Resistance, Independent of Obesity, in Polycystic Ovary SyndromeDiabetes, 1989
- POLYCYSTIC OVARY SYNDROME: A CHANGING PERSPECTIVEClinical Endocrinology, 1989